Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate

Clinical trial NCT00083759 · TERMINATED

Trial details

NCT number: NCT00083759
Sponsor: Biogen
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2004-05-01
Primary completion: 2005-02-01
Enrollment: 299

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.